D. Baylink

发表

Long-term calcitonin therapy in postmenopausal osteoporosis.

W. Nelp, H. Gruber, C. Chesnut, 1984, Metabolism: clinical and experimental.

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.

D. Kiel, S. Silverman, H. Genant, 2000, The American journal of medicine.

Effect of estrone sulfate on postmenopausal bone loss

H. Genant, S. Harris, P. Steiger, 1990, Obstetrics and gynecology.

The effects of fluoride on bone.

H. Gruber, D. Baylink, 1991, Clinical orthopaedics and related research.

Diagnosis of osteoporosis

H. Gruber, D. Baylink, H. Genant, 2013 .

The causes of bone scintigram hot spots in fluoride‐treated osteoporotic patients

J. Wergedal, E. Schulz, D. Sauser, 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action.

W. Nelp, H. Gruber, C. Chesnut, 1983, Metabolism: clinical and experimental.

Osteoporosis associated with pregnancy and lactation: bone biopsy and skeletal features in three patients.

D. Baylink, H. Gruber, D. Baylink, 1984, Metabolic bone disease & related research.

Effect of methandrostenolone on postmenopausal bone wasting as assessed by changes in total bone mineral mass.

W. Nelp, C. Chesnut, J. Denney, 1977, Metabolism: clinical and experimental.

Evaluation of intravenous calcium as therapy for osteoporosis.

W. Nelp, D. Sherrard, C. Chesnut, 1973, The American journal of medicine.

Relation between erythropoiesis and bone metabolism in thalassemia.

J. Burnell, P. Pootrakul, C. Finch, 1981, The New England journal of medicine.

Patients with thalassemia develop osteoporosis, osteomalacia, and hypoparathyroidism, all of which are corrected by transfusion.

J. Burnell, P. Pootrakul, C. Finch, 1987, Birth defects original article series.

Effect of fluoride therapy on nondialyzable urinary hydroxyproline, serum alkaline phosphatase, parathyroid hormone, and 25-hydroxyvitamin D.

J. I. Rader, D. Baylink, G. Vose, 1977, Metabolism: clinical and experimental.

Ex vivo gene therapy with stromal cells transduced with a retroviral vector containing the BMP4 gene completely heals critical size calvarial defect in rats

S. Mohan, J. Wergedal, Shin-Tai Chen, 2002, Gene Therapy.

Skeletal remodelling and bone related hormones in two adults with increased bone mass.

H. Gruber, D. Baylink, E. Manzke, 1982, Metabolism: clinical and experimental.

Relationship between local and total bone mass in osteoporosis.

W. Nelp, J. Wergedal, C. Chesnut, 1975, Metabolism: clinical and experimental.

Osteoblast and osteoclast cell number and cell activity in postmenopausal osteoporosis.

C. Chesnut, C H Chesnut, H. Gruber, 1986, Mineral and electrolyte metabolism.

2 NEW METHODS FOR THE STUDY OF OSTEOPOROSIS AND OTHER METABOLIC BONE DISEASE.

D. Baylink, W. E. Dotter, L. M. Hurxthal, 1964, Lahey Clinic Foundation bulletin.

Regulation of serum 1alpha,25-dihydroxyvitamin D3 by calcium and phosphate in the rat

J. Wergedal, D. Baylink, D. Baylink, 1975, Science.

Fluoride pharmacokinetics in good and poor responders to fluoride therapy

D. Baylink, M. Kraenzlin, D. Baylink, 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Coupling factor.

D. Baylink, J. Farley, E. Puzas, 1982, Advances in Experimental Medicine and Biology.

Diagnosis of bone disease by core biopsies.

H. Gruber, D. Baylink, M. Stauffer, 1981, Seminars in hematology.